Skip to main content
Clinical Trials/ACTRN12605000610639
ACTRN12605000610639
Terminated
Not Applicable

A single-blinded randomised controlled trial to evaluate the pre-treatment effect of two vaginal estradiol doses compared to no treatment on the quality of pap smears in post-menopausal women.

Family Planning NSW0 sites270 target enrollmentOctober 6, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of post-menopausal pap smears
Sponsor
Family Planning NSW
Enrollment
270
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 6, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Naturally menopausal women with no spontaneous menses for the past 12 months; surgically menopausal women aged 20 \- 70 years at least 12 months post\-menopause; women in general good health who require a pap smear according to current guidelines; women who are able to consent and provide contact details.

Exclusion Criteria

  • Use of systemic or vaginal hormone replacement therapy (including Tibolone) within the past 3 months; undiagnosed vaginal bleeding; previous cone biopsy of the cervix; known hypersensitivity or allergy to consituents of vaginal tablet; inability to insert applicator; women requesting liquid\-based cytology.

Outcomes

Primary Outcomes

Not specified

Similar Trials